Navigation Links
Dian Donnai receives lifetime award in genetics from March of Dimes
Date:3/26/2010

ALBUQUERQUE, N.M., MARCH 26, 2010 A pioneering professor and investigator at the forefront of genetic services in the United Kingdom and who helped define rare genetic diseases is the 2010 recipient of the March of Dimes/Colonel Harland Sanders Award for lifetime achievement in the field of genetic sciences.

Dian Donnai, a professor of medical genetics at the University of Manchester and the current President of the European Society for Human Genetics, is known for her research on rare genetic diseases, such as Williams syndrome, in which individuals have heart defects and cognitive disabilities.

"We are proud to recognize Prof. Donnai's research career and her commitment to making genetic services and counseling available to all," said Dr. Michael Katz, senior vice president for Research and Global Programs at the March of Dimes. "Not only has her work helped improve the lives of those affected by rare genetic diseases, but it also has benefited millions of others seeking information and support."

Dr. Katz presented the award to Prof. Donnai today at the Annual Clinical Genetics Meeting of the American College of Medical Genetics, held at the Albuquerque Convention Center.

Professor Donnai is the clinical head of St. Mary's Hospital in the Central Manchester University Hospitals NHS Trust which includes the Genetic Medicine Center. The center serves more than five million people and offers a host of diagnostic, counseling and support services as well as an extensive research program. It is one of the largest and most comprehensive genetics centers in Europe.

Professor Donnai also is executive director of Nowgen, a center originally funded in 2002 by the United Kingdom Departments of Health and Trade & Industry to improve the practice of genetic medicine. She has long been an advocate for more dialogue among patients, the public and the genetic healthcare community Many of Nowgen's initiatives, such as encouraging patient empowerment to studying the economic impact of genetic medicine on the healthcare system, reflect this.

In addition to her research into the causes of Williams syndrome, Professor Donnai also has identified a specific mutation that became known as Donnai-Barrow syndrome, named for her and one of her colleagues. Donnai-Barrow syndrome now is considered part of a group of syndromes characterized by severe functional deficiencies, including severe hearing and vision loss, learning disabilities, as well as internal problems.

Professor Donnai qualified in medicine in London and then trained in pediatrics and genetics in London, Sheffield and Manchester. She is a fellow of the Academy of Medical Services and past president of the Medical Sciences Section of the British Association for the Advancement of Science. She was the consultant advisor to the Chief Medical Officer for England from 1998 to 2004 and was appointed Commander of the Order of British Empire in 2005.

The March of Dimes/Colonel Harland Sanders Award for Lifetime Achievement in the field of genetic sciences is given annually to an individual who has made a significant contribution to the genetic sciences.


'/>"/>

Contact: Elizabeth Lynch
elynch@marchofdimes.com
914-997-4286
March of Dimes Foundation
Source:Eurekalert

Related biology news :

1. WPI receives $1.4 million from NIH for pioneering work on arterial plaque and cardiovascular disease
2. Lombardi receives $7.5 million grant for Breast Cancer Center for Cancer Systems Biology
3. WPI receives $1.2 million NIST award for pioneering study of wireless body area networks
4. Springer editorial board member receives Humboldt Research Award
5. Clemson researcher receives grant to study engineering enrollment of women, minorities
6. NJIT electrical engineer Yanchao Zhang receives NSF CAREER Award
7. Dr. Harmit Malik receives Vilcek Prize for creative promise in biomedical science
8. Oberthur Technologies Receives Product Innovation Award
9. Caltech receives more than $33 million from American Recovery and Reinvestment Act
10. Tulane receives $15 million NIH contract to develop vaccine and treatment for deadly fever
11. Carnegie Mellons John Kitchin receives early career award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... 22, 2016   Acuant , the ... solutions, has partnered with RightCrowd ® ... Visitor Management, Self-Service Kiosks and Continuous Workforce ... add functional enhancements to existing physical access ... venues with an automated ID verification and ...
(Date:6/20/2016)... 20, 2016 Securus Technologies, a leading ... for public safety, investigation, corrections and monitoring announced ... it has secured the final acceptance by all ... Managed Access Systems (MAS) installed. Furthermore, Securus will ... be installed by October, 2016. MAS distinguishes between ...
(Date:6/9/2016)... June 9, 2016  Perkotek an innovation leader in attendance control systems is proud ... work hours, for employers to make sure the right employees are actually signing in, ... ... ... ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... ... June 27, 2016 , ... Cancer experts ... they believe could be a new and helpful biomarker for malignant pleural mesothelioma. ... here to read it now. , Biomarkers are components in the blood, ...
(Date:6/27/2016)... ... 2016 , ... Newly created 4Sight Medical Solutions ... healthcare market. The company's primary focus is on new product introductions, to include ... are necessary to help companies efficiently bring their products to market. , The ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
Breaking Biology Technology: